251 related articles for article (PubMed ID: 18392709)
1. Does ampullary carcinoma arise from distended glands in the papilla of Vater?
Sonoue H; Suda K; Nobukawa B; Abe H; Arakawa A; Hirai S; Matsumoto T
J Hepatobiliary Pancreat Surg; 2008; 15(2):161-8. PubMed ID: 18392709
[TBL] [Abstract][Full Text] [Related]
2. Distended glands or overreplacement of ampullary mucosa at the papilla of Vater.
Suda K; Ootaka M; Yamasaki S; Sonoue H; Matsubara K; Takase M; Nobukawa B; Suzuki F
J Hepatobiliary Pancreat Surg; 2004; 11(4):260-5. PubMed ID: 15368111
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
Zhou H; Schaefer N; Wolff M; Fischer HP
Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of carcinoma of the papilla of Vater.
Fischer HP; Zhou H
J Hepatobiliary Pancreat Surg; 2004; 11(5):301-9. PubMed ID: 15549428
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
Goldstein NS; Bassi D
Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
[TBL] [Abstract][Full Text] [Related]
6. Unique expression of MUC3, MUC5AC and cytokeratins in salivary gland carcinomas.
Lee JH; Lee JH; Kim A; Kim I; Chae YS
Pathol Int; 2005 Jul; 55(7):386-90. PubMed ID: 15982212
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
8. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
9. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
10. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
Kawabata Y; Tanaka T; Nishisaka T; Inao T; Nishi T; Yano S
Diagn Pathol; 2010 Nov; 5():75. PubMed ID: 21106111
[TBL] [Abstract][Full Text] [Related]
12. Adenomyoma and adenomyomatous hyperplasia of the Vaterian system: clinical, pathological, and new immunohistochemical features of 13 cases.
Handra-Luca A; Terris B; Couvelard A; Bonte H; Flejou JF
Mod Pathol; 2003 Jun; 16(6):530-6. PubMed ID: 12808057
[TBL] [Abstract][Full Text] [Related]
13. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A
Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
[TBL] [Abstract][Full Text] [Related]
17. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.
Han L; Pansare V; Al-Abbadi M; Husain M; Feng J
Diagn Cytopathol; 2010 May; 38(5):333-6. PubMed ID: 19856421
[TBL] [Abstract][Full Text] [Related]
18. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
[TBL] [Abstract][Full Text] [Related]
19. Endocrine cells in ampullary carcinoma.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Funata N
J Hepatobiliary Pancreat Surg; 2009; 16(3):322-7. PubMed ID: 19214369
[TBL] [Abstract][Full Text] [Related]
20. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
Xue Y; Vanoli A; Balci S; Reid MM; Saka B; Bagci P; Memis B; Choi H; Ohike N; Tajiri T; Muraki T; Quigley B; El-Rayes BF; Shaib W; Kooby D; Sarmiento J; Maithel SK; Knight JH; Goodman M; Krasinskas AM; Adsay V
Mod Pathol; 2017 Feb; 30(2):255-266. PubMed ID: 27739441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
